The estimated Net Worth of Joel Ackerman is at least $39 Millón dollars as of 27 August 2024. Mr. Ackerman owns over 68,769 units of DaVita Inc stock worth over $16,437,047 and over the last 14 years he sold DVA stock worth over $16,007,020. In addition, he makes $6,538,160 as Chief Financial Officer y Treasurer at DaVita Inc.
Sign up
Mr. Ackerman DVA stock SEC Form 4 insiders trading
Joel has made over 20 trades of the DaVita Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he sold 68,769 units of DVA stock worth $10,663,321 on 27 August 2024.
The largest trade he's ever made was buying 2,710,526 units of DaVita Inc stock on 11 March 2015 worth over $417,393,899. On average, Joel trades about 74,369 units every 74 days since 2010. As of 27 August 2024 he still owns at least 106,741 units of DaVita Inc stock.
You can see the complete history of Mr. Ackerman stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Joel Ackerman biography
Joel Ackerman serves as Chief Financial Officer, Treasurer of the Company. Prior to joining us, Mr. Ackerman was the CEO and a member of the Board of Directors of Champions Oncology, Inc., a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, since October 2010. Mr. Ackerman is currently the Chairman of the Board of Champions Oncology. Mr. Ackerman served as a Managing Director at Warburg Pincus, a global private equity firm, where he led the healthcare services team for nearly 10 years from January 1999 to September 2008. He served on the Board of Directors at Kindred Healthcare, Inc. from December 2008 to July 2018 and served on the Board of Directors of Coventry Health Care, Inc. a national managed care company, from September 1999 until its acquisition by Aetna Inc. in May 2013. Mr. Ackerman is also Chairman of the Board of One Acre Fund, a not-for-profit organization that focuses on smallholder agriculture, and served more than 1,000,000 subsistence farmers in Africa in 2019.
What is the salary of Joel Ackerman?
As the Chief Financial Officer y Treasurer of DaVita Inc, the total compensation of Joel Ackerman at DaVita Inc is $6,538,160. There are 1 executives at DaVita Inc getting paid more, with Javier Rodriguez having the highest compensation of $16,853,500.
How old is Joel Ackerman?
Joel Ackerman is 55, he's been the Chief Financial Officer y Treasurer of DaVita Inc since 2019. There are 9 older and 11 younger executives at DaVita Inc. The oldest executive at DaVita Inc is John Nehra, 71, who is the Independent Director.
What's Joel Ackerman's mailing address?
Joel's mailing address filed with the SEC is 2000 16th St, Denver, CO 80202, USA.
Insiders trading at DaVita Inc
Over the last 22 years, insiders at DaVita Inc have traded over $539,813,199 worth of DaVita Inc stock and bought 20,841,023 units worth $1,590,012,094 . The most active insiders traders include Hathaway Incbuffett Warren ..., R. Ted Weschler, y Kent J Thiry. On average, DaVita Inc executives and independent directors trade stock every 12 days with the average trade being worth of $12,626,872. The most recent stock trade was executed by Kathleen Alyce Waters on 28 August 2024, trading 26,333 units of DVA stock currently worth $1,999,991.
What does DaVita Inc do?
about davita kidney care davita kidney care is a division of davita healthcare partners inc., a fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the united states and abroad. a leading provider of dialysis services in the united states, davita kidney care treats patients with chronic kidney failure and end stage renal disease. davita kidney care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. as of march 31, 2015, davita kidney care operated or provided administrative services at 2,197 outpatient dialysis centers located in the united states serving approximately 174,000 patients. the company also operated 93 outpatient dialysis centers located in 10 countries outside the united states. davita kidney care supports numerous programs dedicated to creating positive,
What does DaVita Inc's logo look like?
Complete history of Mr. Ackerman stock trades at Champions Oncology Inc y DaVita Inc
DaVita Inc executives and stock owners
DaVita Inc executives and other stock owners filed with the SEC include:
-
Javier Rodriguez,
Chief Executive Officer, Director -
Joel Ackerman,
Chief Financial Officer, Treasurer -
Charles Berg,
Director -
Kathleen Waters,
Chief Legal Officer -
Javier J. Rodriguez,
CEO & Exec. Director -
LeAnne Zumwalt,
Group Vice President, Government Affairs -
Michael David Staffieri,
Chief Operating Officer of Kidney Care -
Joel Ackerman,
CFO & Treasurer -
Kathleen Alyce Waters,
Chief Legal and Public Affairs Officer -
James O. Hearty,
Chief Compliance Officer -
Barbara Desoer,
Independent Director -
Pascal Desroches,
Independent Director -
Pamela Arway,
Independent Chairman of the Board -
John Nehra,
Independent Director -
Paul Diaz,
Independent Director -
Phyllis Yale,
Independent Director -
Jim Gustafson,
Vice President - Investor Relations -
Paula Price,
Independent Director -
Shawn Guertin,
Director -
Kenny Gardner,
Chief People Officer - DaVita Kidney Care -
James Hearty,
Chief Compliance Officer -
John Winstel,
Chief Accounting Officer -
Kenneth Gardner Smith,
Chief People Officer -
Kenny Gardner,
Chief People Officer -
Atul Mathur,
Exec. VP of Global Operations -
Bill Myers,
VP of Marketing & Communications -
John D. Winstel,
Chief Accounting Officer -
Jeanine Marie Jiganti,
Chief Compliance Officer -
Peter T Grauer,
Director -
James K Hilger,
Vice President and Controller -
William L Roper,
Director -
Carol Anthony Davidson,
Director -
Roger Valine,
Director -
Joseph C Mello,
Chief Operations Officer -
Allen Nissenson,
Chief Medical Officer -
Dennis W Pullin,
Director -
R. Ted Weschler,,
-
Hathaway Incbuffett Warren ...,
-
Robert J Margolis,
Co-Chairman of the Board -
Laura Mildenberger,
SVP & Chief People Officer -
Kim M Rivera,
VP, Gen. Counsel & Secretary -
Dennis Kogod,
President - West -
Garry E Menzel,
Senior Vice President, Finance -
David T Shapiro,
Chief Compliance Officer -
Charles J Mcallister,
Chief Medical Officer -
Steven J Udicious,
V.P., Sec. and Gen. Counsel -
Joseph Schohl,
VP, Secretary & Gen. Counsel -
Willard Woodson Jr Brittain,
Director -
Nancy Ann Deparle,
Director -
Mary Kowenhoven,
Vice President - Strategy -
Thomas O Usilton,
Group Vice President -
Patricia Jones,
Chief People Officer -
C Raymond Jr Larkin,
Director -
Christopher J Riopelle,
Chief Compliance Officer -
Thomas L Kelly,
Executive Vice President -
Luis Borgen,
Chief Financial Officer -
Georgina Randolph,
Senior Vice President -
Richard B Fontaine,
Director -
Mark G Harrison,
Chief Financial Officer -
Richard K Whitney,
Chief Financial Officer -
Richard C Vaughan,
Director -
Gary Beil,
Vice President and Controller -
Patrick A Broderick,
VP, Secretary & Gen. Counsel -
Lori Richardson Pelliccioni,
Cheif Compliance Officer -
Michele J Hooper,
Director -
Michael David Staffieri,
Chief Operating Officer, DKC -
Kent J Thiry,
Executive Chairman -
Gregory J. Moore,
Director -
Jason M. Hollar,
Director -
Adam H Schechter,
Director -
Christopher Michael Berry,
Chief Accounting Officer -
Wendy Lee Schoppert,
Director